Addario Lung Cancer Medical Institute (ALCMI) and CASTLE Network Study Initiative

Get New Treatments Alerts:

ALCMI aims at making Lung Cancer a survivable disease.

Addario Lung Cancer Medical Institute (ALCMI) dedicates itself to active research, development, and delivery of new lung cancer treatment options. Aimed at improving the standard of lung cancer treatments, it is a patient focused and patient-founded non-profit research association.

Establishment and Goals of ALCMI

ALCMI came to existence in 2008. Over 70 leading Lung Cancer researchers, patients, and clinicians of the world, recognized the need for a data and specimen bank to facilitate quick research and development of customized therapies for Lung Cancer. In a Bonnie J. Addario Lung Cancer Foundation (BJALCF) sponsored summit in 2007, it was decided to form ALCMI, a non-profit lung cancer research organization. Collection and analysis of blood and tissue from patients was found to be crucial in research and development.

The goal of ALCMI is:

To Make Lung Cancer a survivable disease.

ALCMI, with its unique centrally coordinated scientific planning strives to make a difference right Now. The researchers here are pooling knowledge, data, and specimens to form a data and bio repository. Researchers from all over the US can use the knowledge and resources made available here for improving lung cancer treatment and delivering targeted drugs.

CASTLE Network of Study – An Initiative of ALCMI

Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network is a multi-institutional tissue and data repository. Biospecimens like blood samples and tissue sample will be collected from lung cancer patients, examined, and investigated for specific predetermined biomarkers of clinical significance. These specimens and generated data can be used for future lung cancer research projects by various associated institutions and research networks in the US.

The CASTLE Network study is a first of its kind collection of lung cancer tissues and specimens and has the potential to provide vital information to various lung cancer research programs. The study aims to integrate clinicians and investigators into the translational research efforts. The specimens collected would serve as an open resource for community researchers, academicians, NIH, biopharmaceutical industry etc in addition to researchers with the sole aim of bringing about new improved lung cancer treatments and drugs to patients in need.

If you are interested in enrolling for the CASTLE Network study, you can fill in the form here. Your contribution can help researchers and physicians find a new treatment or drug for people suffering from lung cancer.